Navigation Links
Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
Date:7/20/2009

-out period. The primary endpoint was reduction in A1C; secondary endpoints included change in body weight along with other parameters of glucose control, cardiovascular health, hypoglycemia and patient-reported outcomes. Subjects in both treatment groups are continuing in an open-ended extension study.

The companies plan to present the full data set at a major medical meeting and submit the data for publication.

About Diabetes

Diabetes affects more than 23 million people in the U.S. and an estimated 246 million adults worldwide.(i,ii) Approximately 90-95 percent of those affected have type 2 diabetes. Diabetes is the fifth leading cause of death by disease in the U.S. and results in approximately $174 billion per year in direct and indirect medical expenses.(iii)

According to the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey, approximately 60 percent of people with diabetes do not achieve their target blood sugar levels with their current treatment regimen.(iv) In addition, 85 percent of type 2 diabetes patients are overweight and 55 percent are considered obese.(v) Data indicate that weight loss (even a modest amount) supports patients in their efforts to achieve and sustain glycemic control.(vi,vii)

About Amylin, Lilly and Alkermes
Amylin, Lilly and Alkermes are working together to develop exenatide once weekly, a subcutaneous injection of exenatide for the treatment of type 2 diabetes based on Alkermes' proprietary technology for long-acting medications. Exenatide once weekly is not currently approved by any regulatory agencies.

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin's research and development activities leverage the Company's expertise in metabolism
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
2. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
3. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
4. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
5. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
6. Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
7. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
8. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
9. Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
10. Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009
11. The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Valeant ... VRX ) (TSX: VRX) today announced ... at its 2013 annual meeting of ... the vote for the election of ... H. Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo Melas-Kyriazi237,081,508615,174G. Mason ...
(Date:5/21/2013)... CINCINNATI , May 21, 2013  Tom Daulton, CEO ... named Dealmaker of the Year by the Cincinnati ... Daulton, who was nominated by another local top executive who ... the Mammotome® brand from Ethicon Endo-Surgery in March of 2010. ... Deal Maker Awards program, presented by Huntington Bank, on May ...
(Date:5/21/2013)... N.J. , May 21, 2013 /PRNewswire-iReach/ -- The ... in NJ has attracted the greatest number of ... its President, Mark Alexay .  ... plans to attend this year.  The show,s still 4 ... different companies.  This is a big surprise and ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2
... Ellman International, Inc ., a New York based manufacturer ... today announced the appointment of Dennis S. Herman to ... Herman brings over 20 years of sales leadership ...  "Dennis, proven success in leading sales teams to significant ...
... 1, 2011 Lance® Sandwich Crackers is partnering ... support the organization,s efforts to find better treatments and a ... diabetes is an autoimmune disease that can strike at any ... insulin needed to turn food into energy.  People with the ...
Cached Medicine Technology:Ellman International Announces New US Sales Executive 2Lance® Joins JDRF in the Fight Against Type 1 Diabetes 2Lance® Joins JDRF in the Fight Against Type 1 Diabetes 3
(Date:5/21/2013)... MedMar Healing Center announces their participation in the CannaCommunity ... businesses, including MedMar Healing Center, doctors, and clubs, are coming ... to raise food to help area kids who have been ... years. , “We like being able to give back ... Chloupek of MedMar Healing Center. “Taking part in the food ...
(Date:5/21/2013)... (May 21, 2013) Research into genetic features of ... of Colorado School of Medicine may lead to improved ... paper published online by JAMA . , The ... survival in some cases of pulmonary fibrosis, a chronic ... As a result of the study, researchers may want ...
(Date:5/21/2013)... New York, New York (PRWEB) May 21, 2013 ... da Vinci surgery robot lawsuit is nearing its ... According to Bloomberg.com, during closing statements yesterday, an ... car dealership, alleging the company wanted to tie sales ... to do all the training to keep control of ...
(Date:5/21/2013)... 2013 Two executives from human resources ... identify which strategies can be most effective to better ... the members who are taking them, in an upcoming ... “How to Manage Specialty Drugs to Reduce Costs and ... the main driver for rising prescription drug costs, which ...
(Date:5/21/2013)... va (PRWEB) May 21, 2013 ... critical technology and management consulting solutions to the ... of Business Development. In the newly created ... leading all aspects of the firm’s business development ... and proposal management functions, and leading strategies to ...
Breaking Medicine News(10 mins):Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Sept. ... a placebo pill to treat a low libido reported ... is evidence of the powerful and somewhat mysterious mind-body ... Viagra and Cialis revolutionized the treatment of male sexual ...
... Texas is recruiting patients for a Phase III lung ... previously treated patients. The trial will evaluate the ... for the treatment of Non-Small Cell Lung Cancer (NSCLC). ... Cancer Immunotherapy) study is expected to be one of ...
... bacteria that inhabit the intestine provide the environmental trigger ... who are genetically susceptible to inflammatory bowel disease (IBD), ... researchers has found. Inflammatory bowel disease results ... immune system and the microbes that inhabit the intestine. ...
... at Washington University School of Medicine in St. Louis ... the effectiveness of radiation for hard-to-treat cancers. The ... Cancer Institute , focuses on the role of the ... and functioning of blood vessel networks that feed malignant ...
... By Kathleen Doheny HealthDay Reporter , ... smoking in workplaces and public settings seem to show ... is linked with a decline in hospital admissions for ... to tobacco smoke increases the incidence and severity of ...
... -- A new study is helping unravel an enduring mystery ... affected by the disorder than girls. An international team ... and Mental Health in Toronto, examined specific genes in almost ... others with intellectual disability. They then compared that data to ...
Cached Medicine News:Health News:Placebo Pill Gives Boost to Some Women's Sex Drive 2Health News:Bacteria identified that may lead to inflammatory bowel disease in certain individuals 2Health News:Novel target for existing drug may improve success of radiation therapy 2Health News:Novel target for existing drug may improve success of radiation therapy 3Health News:Smoke-Free Laws May Help Kids Breathe Easier 2Health News:Research Sheds Light on Why Autism Is More Prevalent in Boys 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: